Muhiddin Er

Muhiddin Er

Necmettin Erbakan University - Konya / Türkiye
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5310648
Necmettin Erbakan Üniversitesi
person_outline Muhiddin Er's MOST POPULAR ARTICLES
1-) Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancerS Kahraman, E Erul, M Seyyar, O Gumusay, E Bayram, BC Demirel, ...Future Oncology 19 (10), 727-736, 202342023
2-) Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?MZ Kocak, M Er, M Ugrakli, E Hendem, M Araz, MK Eryilmaz, M ArtacEuropean Journal of Clinical Pharmacology 79 (4), 485-491, 202342023
3-) Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastasesS Kahraman, S Karakaya, MA Kaplan, SS Goksu, A Ozturk, ZS Isleyen, ...Scientific Reports 14 (1), 5820, 202432024
4-) Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?M Korkmaz, MK Eryılmaz, MM Er, MZ Koçak, A Demirkıran, M Karaağaç, ...Journal of Gastrointestinal Cancer 54 (3), 962-969, 202332023
5-) Ribociclib-induced hepatotoxicityMM Er, M Araz, E Hendem, MK Eryılmaz, M ArtaçJournal of Oncology Pharmacy Practice 29 (5), 1275-1277, 202332023